Literature DB >> 19016154

Atherosclerosis in hemodialysis patients--the role of microinflammation.

Sebastjan Bevc1, Samir Sabic, Radovan Hojs.   

Abstract

INTRODUCTION: Cardiovascular diseases (CVDs) are the most frequent cause of morbidity and mortality in patients with end-stage renal disease, and the risk for coronary heart disease is higher among the hemodialysis (HD) patients than in the general population. This excess risk for coronary heart disease is not entirely explained by traditional risk factors for CVDs. The aim of the study was to determine possible correlations between asymptomatic atherosclerosis and inflammatory markers (high sensitivity CRP [hsCRP], interleukin 6 [IL-6], tumor necrosis factor-alpha [TNF-alpha], interleukin 2 receptor [IL-2R], and selective adhesion molecules ICAM-1 and VCAM-1) in HD patients. PATIENTS AND METHODS: In our study, 95 HD patients, 56 (59%) male and 39 (41%) female, were included. The mean age was 60 +/- 13 years, ranging from 22-81 years. Using B-mode ultrasonography (US), we measured intima-media thickness (IMT) and plaque occurrence (markers of asymptomatic atherosclerosis) in carotid arteries in these patients. In the 1-4 weeks after US examination, we took blood samples from patients to determine serum concentrations of inflammatory markers.
RESULTS: The mean IMT value was 0.83 +/- 0.21 mm, ranging from 0.5 to 2 mm. The plaques were found in 63 (84%) of HD patients. Correlations between IMT values and serum concentrations of IL-2R (r = 0.269; p < 0.022) and VCAM-1 (r = 0.290; p < 0.014) were found. Multiple linear regression analysis showed relationship between IMT values and IL-2R (p = 0.049). No relationship between inflammatory markers and plaques was found.
CONCLUSION: The results indicate that atherosclerosis in HD patients correlates with some nontraditional risk factors--the markers of inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19016154     DOI: 10.1080/08860220802406385

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  7 in total

1.  Correlative association of interleukin-6 with intima media thickness: a meta-analysis.

Authors:  Bo Zhang; Jing Wang; Yong Xu; Xiao Zhou; Junsong Liu; Jing Xu; Bo Li; Guang Zhi
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  Hepatocyte growth factor (HGF) and hemodialysis: physiopathology and clinical implications.

Authors:  Carmelo Libetta; Pasquale Esposito; Claudia Martinelli; Fabrizio Grosjean; Marilena Gregorini; Teresa Rampino; Antonio Dal Canton
Journal:  Clin Exp Nephrol       Date:  2015-12-16       Impact factor: 2.801

3.  Cardiovascular risk may be increased in women with unexplained infertility.

Authors:  Fatma Ferda Verit; Fadile Yildiz Zeyrek; Ali Galip Zebitay; Hurkan Akyol
Journal:  Clin Exp Reprod Med       Date:  2017-03-31

4.  The Effect of Vitamin D Administration on Intracellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 Levels in Hemodialysis Patients: A Placebo-controlled, Double-blinded Clinical Trial.

Authors:  Afsoon Emami Naeini; Firouzeh Moeinzadeh; Sahar Vahdat; Akbar Ahmadi; Zahra Parin Hedayati; Safoora Shahzeidi
Journal:  J Res Pharm Pract       Date:  2017 Jan-Mar

5.  High sensitivity C-reactive protein as a predictive of intima-media thickness in patients with end-stage renal disease on regular hemodialysis.

Authors:  Lestariningsih Lestariningsih; Suharyo Hardisaputro; Ayudyah Nurani; Damai Santosa; Gunawan Santoso
Journal:  Int J Gen Med       Date:  2019-06-13

6.  Changes in microparticle profiles by vitamin D receptor activation in chronic kidney disease - a randomized trial.

Authors:  Kristina Lundwall; Josefin Mörtberg; Fariborz Mobarrez; Stefan H Jacobson; Gun Jörneskog; Jonas Spaak
Journal:  BMC Nephrol       Date:  2019-08-01       Impact factor: 2.388

Review 7.  Diabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk.

Authors:  Nejc Piko; Sebastjan Bevc; Robert Ekart; Tadej Petreski; Nina Vodošek Hojs; Radovan Hojs
Journal:  World J Diabetes       Date:  2021-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.